Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2022 08:30 ET | Source: Liver Institute Northwest

Liver Institute Northwest Participating in RESPONSE, a Global Phase 3 Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC)

SEATTLE, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Liver Institute Northwest is enrolling participants into RESPONSE, a global phase 3 clinical research study evaluating the safety and efficacy of...